aprotinin

Bayer Halts Sales of Anti-Bleeding Drug - Trasylol

sai's picture
Submitted by sai on Wed, 11/07/2007 - 00:20.
in

The U.S. Food and Drug Administration [(FDA)] today announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death. Trasylol, also known as aprotinin, works by blocking enzymes that dissolve blood clots. It is designed to stem blood loss and enable patients receiving heart bypass surgery to avoid transfusions.

Syndicate content